Testing effectiveness (Phase 2)Study completedNCT00761215
What this trial is testing
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Who this might be right for
Skin Diseases, InfectiousSkin Diseases, Bacterial
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 192